|
⚲
|
| Keyboard |
| Resnick Paul F
✚
|
|
|---|---|
| CIK # | 0001669636 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001669636] | |
| 4 | [0001669636] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Mabvax Therapeutics Holdings Inc | |
| Resnick Paul F |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Mabvax Therapeutics Holdings Inc MBVX
Option to Purchase Common Stock · derivative
|
2018-02-21 | Grant | 80,000 | $0.00 | |
|
Mabvax Therapeutics Holdings Inc MBVX
Common Stock
|
2018-01-16 | Sell | 3,071 | $0.92 | 2,825 |
|
Mabvax Therapeutics Holdings Inc MBVX
Common Stock
|
2018-01-12 | Sell | 824 | $0.96 | 791 |
|
Mabvax Therapeutics Holdings Inc MBVX
Common Stock
|
2018-01-11 | Sell | 2,837 | $0.98 | 2,780 |
|
Mabvax Therapeutics Holdings Inc MBVX
Common Stock
|
2018-01-10 | Sell | 4,879 | $0.96 | 4,684 |
|
Mabvax Therapeutics Holdings Inc MBVX
Common Stock
|
2018-01-08 | Option exercise | 29,944 | $0.00 | |
|
Mabvax Therapeutics Holdings Inc MBVX
Restricted Stock Unit · derivative
|
2018-01-08 | Option exercise | 29,944 | ||
|
Mabvax Therapeutics Holdings Inc MBVX
Restricted Stock Unit · derivative
|
2017-10-02 | Grant | 22,695 | ||
|
Mabvax Therapeutics Holdings Inc MBVX
Restricted Stock Unit · derivative
|
2017-09-15 | Grant | 7,249 | ||
|
Mabvax Therapeutics Holdings Inc MBVX
Option to Purchase Common Stock · derivative
|
2017-02-06 | Grant | 35,000 | $2.99 | 104,650 |
|
Mabvax Therapeutics Holdings Inc MBVX
Option to Purchase Common Stock · derivative
|
2017-01-01 | Grant | 15,200 | $3.38 | 51,376 |
|
Mabvax Therapeutics Holdings Inc MBVX
Option to Purchase Common Stock · derivative
|
2016-08-29 | Grant | 15,200 | $5.00 | 76,000 |